PHP
Parkman Healthcare Partners Portfolio holdings
AUM
$864M
This Quarter Return
+14.61%
1 Year Return
+33.7%
3 Year Return
+258.24%
5 Year Return
+878.92%
10 Year Return
–
AUM
$378M
AUM Growth
+$378M
(+9%)
Cap. Flow
+$11M
Cap. Flow
% of AUM
2.9%
Top 10 Holdings %
Top 10 Hldgs %
31.74%
Holding
97
New
18
Increased
35
Reduced
31
Closed
12
Top Buys
| 1 |
Masimo
MASI
|
$8.26M |
| 2 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$5.72M |
| 3 |
Immunic
IMUX
|
$4.83M |
| 4 |
SDC
SmileDirectClub, Inc. Class A Common Stock
SDC
|
$4.21M |
| 5 |
Zymeworks
ZYME
|
$3.96M |
Top Sells
| 1 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
$6.79M |
| 2 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$6.37M |
| 3 |
GNMK
GenMark Diagnostics, Inc
GNMK
|
$4.54M |
| 4 |
Madrigal Pharmaceuticals
MDGL
|
$3.77M |
| 5 |
AXNX
Axonics, Inc. Common Stock
AXNX
|
$3.32M |
Sector Composition
| 1 | Healthcare | 92.08% |
| 2 | Technology | 1.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
XLRN
26
DELISTED
Acceleron Pharma Inc.
XLRN
| $5.63M | 1.49% |
50,016
-7,484
| -13% | -$842K |
|
27
Kodiak Sciences
KOD
$453M
| $5.49M | 1.45% |
92,733
+27,515
| +42% | +$1.63M |
|
|
TRIL
28
DELISTED
Trillium Therapeutics Inc.
TRIL
| $5.33M | 1.41% |
375,063
+75,063
| +25% | +$1.07M |
|
|
NUAN
29
DELISTED
Nuance Communications, Inc.
NUAN
| $5.31M | 1.41% |
160,075
+35,019
| +28% | +$1.16M |
|
30
Immunovant
IMVT
$2.91B
| $5.28M | 1.4% |
150,151
+25,026
| +20% | +$881K |
|
|
SPNE
31
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $5.27M | 1.4% |
368,813
+123,028
| +50% | +$1.76M |
|
32
Xenon Pharmaceuticals
XENE
$2.99B
| $5.15M | 1.36% |
464,825
-125,442
| -21% | -$1.39M |
|
|
ICAD
33
DELISTED
iCAD Inc
ICAD
| $5.13M | 1.36% |
581,752
-143,838
| -20% | -$1.27M |
|
|
GWPH
34
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $4.87M | 1.29% |
50,000
-69,778
| -58% | -$6.79M |
|
35
Aclaris Therapeutics
ACRS
$223M
| $4.74M | 1.25% |
1,842,661
+145,304
| +9% | +$373K |
|
36
KORU Medical Systems
KRMD
$187M
| $4.56M | 1.21% |
631,226
-90,759
| -13% | -$655K |
|
37
Alnylam Pharmaceuticals
ALNY
$58.6B
| $4.49M | 1.19% |
30,863
-5,000
| -14% | -$728K |
|
|
SDC
38
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
| $4.21M | 1.11% |
+360,000
| New | +$4.21M |
|
39
Arcus Biosciences
RCUS
$1.24B
| $4.03M | 1.07% |
235,038
+75,038
| +47% | +$1.29M |
|
|
40
Zymeworks
ZYME
$1.07B
| $3.96M | 1.05% |
+85,000
| New | +$3.96M |
|
|
CDMO
41
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $3.69M | 0.98% |
484,247
+359,247
| +287% | +$2.74M |
|
|
KDMN
42
DELISTED
Kadmon Holdings, Inc.
KDMN
| $3.43M | 0.91% |
875,150
+150,150
| +21% | +$589K |
|
43
Alphatec Holdings
ATEC
$2.35B
| $3M | 0.79% |
451,672
+25,073
| +6% | +$166K |
|
44
InfuSystem Holdings
INFU
$215M
| $2.99M | 0.79% |
232,935
+17,452
| +8% | +$224K |
|
45
Idexx Laboratories
IDXX
$50.7B
| $2.95M | 0.78% |
+7,500
| New | +$2.95M |
|
|
MTEM
46
DELISTED
Molecular Templates, Inc.
MTEM
| $2.93M | 0.77% |
267,938
-74,937
| -22% | -$818K |
|
47
BridgeBio Pharma
BBIO
$9.91B
| $2.82M | 0.75% |
75,228
+13
| +0% | +$488 |
|
48
89bio
ETNB
$1.37B
| $2.82M | 0.75% |
+110,000
| New | +$2.82M |
|
49
BioCryst Pharmaceuticals
BCRX
$1.74B
| $2.75M | 0.73% |
800,740
-99,868
| -11% | -$343K |
|
50
Mersana Therapeutics
MRSN
$34.8M
| $2.61M | 0.69% |
140,066
-109,934
| -44% | -$2.05M |
|